Brennan Ita M 4

4 · Planet Labs PBC · Filed Apr 17, 2026

AI-generated summary of this filing

Updated Apr 17, 2026

Planet Labs (PL) Director Brennan Ita Sells 36,500 Shares

What Happened

Brennan Ita, a director of Planet Labs PBC (PL), sold 36,500 shares in an open-market sale on April 15, 2026. The weighted-average sale price was $33.91, for total proceeds of approximately $1,237,580. The sales were executed under a Rule 10b5-1 trading plan.

Key Details

Transaction type: Sale (code S), open-market execution under a 10b5-1 plan adopted Jan 14, 2026.
Date of transaction: April 15, 2026; filing date: April 17, 2026 (timely filing).
Prices: multiple trades at $32.86–$35.14; reported price is the weighted average $33.91.
Shares sold: 36,500; total proceeds ≈ $1,237,580.
Shares owned after transaction: not explicitly stated in the summary data provided. The filing notes RSUs totaling 35,946 (3,478 vesting in equal quarterly installments and 32,468 vesting on the earlier of the first anniversary of grant or the issuer’s next annual meeting) that represent contingent rights to receive one share each.
Footnote: Reporting person will provide per-trade breakdown of quantities/prices upon request by the SEC staff, issuer, or a security holder.

Context

A Rule 10b5-1 plan is a pre-scheduled trading arrangement that often governs timing and amounts of trades; sales under such plans are generally seen as pre-planned transactions rather than ad hoc insider timing. RSUs noted in the filing are contingent rights to receive shares and have specified vesting schedules.

Form 4

Period: 2026-04-15

Director

Transactions

Sale
Class A Common Stock
[F1][F2][F3]
2026-04-15$33.91/sh−36,500$1,237,580→ 264,158 total

Footnotes (3)

[F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 14, 2026.
[F2]The sales were executed in multiple trades at prices ranging from $32.86 to $35.14. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
[F3]Includes (a) 3,478 RSUs that vest in equal quarterly installments on the 15th of June; and (b) 32,468 RSUs which fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the issuer's next annual meeting of stockholders to occur following the grant. The RSUs represent a contingent right to receive one share of issuer's Class A Common Stock each and have no expiration date.

Signature

By: /s/ LeeAnn Linck, Attorney-in-fact for: Ita M Brennan|2026-04-17

1 file